Literature DB >> 36254024

Predictor assessment of complete miscarriage after medical treatment for early pregnancy loss in women with previous cesarean section.

Ye Lu1, Ruide Su, Ruixin Chen, Wenrong Wang, Jian An.   

Abstract

This study aimed to evaluate clinical predictors associated with complete miscarriage after medical treatment for early pregnancy loss (EPL) in women with previous cesarean section. Patients with retained uterine content after expulsion followed by administration of mifepristone and misoprostol were included if they chose continued medical treatment rather than surgical intervention. Clinical characteristics including maternal age, gravidity, parity, history of previous cesarean section and ultrasound findings regarding average diameter of the gestational sac, uterine position, width, and blood flow signal of the residual uterine content after expulsion of the gestational sac were included in the analysis to determine predictors of complete miscarriage. A recursive partitioning analysis (RPA) was used to divide the patients into probability groups and assess their probability of complete miscarriage. A total of 89 patients were analyzed. The complete miscarriage rate was 58.43% overall. Multivariable logistic regression analysis showed that the width and blood flow signal of the residual after expulsion were both independent predictors for complete miscarriage (all P < .05). Patients were divided into high-probability (no blood flow signal, width of residual <1 cm), intermediate-probability (no blood flow signal, width of residual ≥1 cm; blood flow signal, width of residual <1 cm), and low-probability (blood flow signal, width of residual ≥ 1 cm) groups by RPA according to these 2 factors. The incidences of complete miscarriage were 88.24%, 67.57%, and 34.29%, respectively, P < .001). Surgical evacuation may be avoided in patients without ultrasonic blood flow of the uterine residual and width of the residual <1 cm. More active treatment could be recommended for patients with ultrasonic blood flow of the uterine residual and width of the residual ≥ 1 cm. Clinicians and patients should be aware of these differences when proceeding with medical treatment for EPL patients with previous cesarean section.
Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36254024      PMCID: PMC9575734          DOI: 10.1097/MD.0000000000031180

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  20 in total

Review 1.  Modern management of miscarriage: is there a place for non-surgical treatment?

Authors:  D Jurkovic
Journal:  Ultrasound Obstet Gynecol       Date:  1998-03       Impact factor: 7.299

2.  Surgical Management of Incomplete Abortion by Manual Vacuum Aspiration (MVA).

Authors:  M Chowdhury; D Rahman
Journal:  Mymensingh Med J       Date:  2019-10

3.  Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of treatment success from a randomized trial.

Authors:  Sarita Sonalkar; Nathanael Koelper; Mitchell D Creinin; Jessica M Atrio; Mary D Sammel; Arden McAllister; Courtney A Schreiber
Journal:  Am J Obstet Gynecol       Date:  2020-04-17       Impact factor: 8.661

4.  A comparison of medical management with misoprostol and surgical management for early pregnancy failure.

Authors:  Jun Zhang; Jerry M Gilles; Kurt Barnhart; Mitchell D Creinin; Carolyn Westhoff; Margaret M Frederick
Journal:  N Engl J Med       Date:  2005-08-25       Impact factor: 91.245

Review 5.  Medical methods for first trimester abortion.

Authors:  Jing Zhang; Kunyan Zhou; Dan Shan; Xiaoyan Luo
Journal:  Cochrane Database Syst Rev       Date:  2022-05-24

6.  Factors related to successful misoprostol treatment for early pregnancy failure.

Authors:  Mitchell D Creinin; Xiangke Huang; Carolyn Westhoff; Kurt Barnhart; Jerry M Gilles; Jun Zhang
Journal:  Obstet Gynecol       Date:  2006-04       Impact factor: 7.661

7.  Clinical indicators for success of misoprostol treatment after early pregnancy failure.

Authors:  C Robledo; J Zhang; J Troendle; K Barnhart; M D Creinin; C Westhoff; X Huang; M Frederick
Journal:  Int J Gynaecol Obstet       Date:  2007-06-27       Impact factor: 3.561

8.  Medical treatment for early fetal death (less than 24 weeks).

Authors:  Marike Lemmers; Marianne Ac Verschoor; Bobae Veronica Kim; Martha Hickey; Juan C Vazquez; Ben Willem J Mol; James P Neilson
Journal:  Cochrane Database Syst Rev       Date:  2019-06-17

9.  Mifepristone and misoprostol versus misoprostol alone for uterine evacuation after early pregnancy failure: study protocol for a randomized double blinded placebo-controlled comparison (Triple M Trial).

Authors:  Joyce van den Berg; Charlotte C Hamel; Marcus P Snijders; Sjors F Coppus; Frank P Vandenbussche
Journal:  BMC Pregnancy Childbirth       Date:  2019-11-27       Impact factor: 3.007

10.  Operative hysteroscopy-assisted pregnancy termination after failed surgical abortion in missed abortion of woman with complete septate uterus.

Authors:  Soomin Ryu; Hye Won Baek; Inha Lee; Young Bin Won; Heeyon Kim; Jae Hoon Lee; Bo Hyon Yun; Joo Hyun Park; Seok Kyo Seo; SiHyun Cho; Young Sik Choi; Byung Seok Lee
Journal:  Obstet Gynecol Sci       Date:  2019-12-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.